India to Poland: Emtricitabine Export Trade Route

The India to Poland Emtricitabine corridor is one of India's established pharmaceutical export routes, with 126 shipments documented worth a combined $5.3M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 47% of all export value, reflecting the consolidated nature of India's emtricitabine manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $41.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with emtricitabine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 11.2%, placing it at rank #3 among India's top emtricitabine export destinations globally.

On the import side, key buyers of Indian emtricitabine in Poland include SYNOPTIS INDUSTRIAL SP .ZO.O, SYNOPTIS INDUSTRIAL SP ,ZO,O , SYNOPTIS INDUSTRIAL SP ZO OUKARKOWIAKOW and 16 others. SYNOPTIS INDUSTRIAL SP .ZO.O is the single largest importer with 16 shipments valued at $1.4M USD.

India's emtricitabine exports to Poland are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 40 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD — together account for 96% of total trade value on this route. The average shipment value of $41.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as medicines. emtricitabine 200mg + tenofov and drugs and pharmaceuticals harmless medicines emtricitabine and tenofovir disoproxil film coated tablets 200 mg/ 245 mg, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SYNOPTIS INDUSTRIAL SP .ZO.O is the largest importer with 16 shipments worth $1.4M USD — representing 27% of all emtricitabine imports from India on this route. A total of 19 buyers are active on this corridor.